| 1. Parker MA, Marona-Lewicka D, Kurrasch D, Shulgin AT, Nichols DE.. (1998) Synthesis and pharmacological evaluation of ring-methylated derivatives of 3,4-(methylenedioxy)amphetamine (MDA)., 41 (6): [PMID:9526575] [10.1021/jm9705925] |
| 2. Martin GE, Elgin RJ, Mathiasen JR, Davis CB, Kesslick JM, Baldy WJ, Shank RP, DiStefano DL, Fedde CL, Scott MK.. (1989) Activity of aromatic substituted phenylpiperazines lacking affinity for dopamine binding sites in a preclinical test of antipsychotic efficacy., 32 (5): [PMID:2565400] [10.1021/jm00125a020] |
| 3. Blair JB, Marona-Lewicka D, Kanthasamy A, Lucaites VL, Nelson DL, Nichols DE.. (1999) Thieno[3,2-b]- and thieno[2,3-b]pyrrole bioisosteric analogues of the hallucinogen and serotonin agonist N,N-dimethyltryptamine., 42 (6): [PMID:10090793] [10.1021/jm980692q] |
| 4. Nichols DE, Jadhav KP, Oberlender RA, Zabik JE, Bossart JF, Hamada A, Miller DD.. (1984) Synthesis and evaluation of substituted 2-phenylcyclobutylamines as analogues of hallucinogenic phenethylamines: lack of LSD-like biological activity., 27 (9): [PMID:6471065] [10.1021/jm00375a004] |
| 5. Hoffman AJ, Nichols DE.. (1985) Synthesis and LSD-like discriminative stimulus properties in a series of N(6)-alkyl norlysergic acid N,N-diethylamide derivatives., 28 (9): [PMID:4032428] [10.1021/jm00147a022] |
| 6. Andrews PR, Craik DJ, Martin JL.. (1984) Functional group contributions to drug-receptor interactions., 27 (12): [PMID:6094812] [10.1021/jm00378a021] |
| 7. Johnson MP, Frescas SP, Oberlender R, Nichols DE.. (1991) Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphenyl)-2-aminopropane and 5-methoxy-6-methyl-2-aminoindan: similarities to 3,4-(methylenedioxy)methamphetamine (MDMA)., 34 (5): [PMID:1674539] [10.1021/jm00109a020] |
| 8. Nichols DE, Hoffman AJ, Oberlender RA, Jacob P, Shulgin AT.. (1986) Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class., 29 (10): [PMID:3761319] [10.1021/jm00160a035] |
| 9. Oberlender R, Pfaff RC, Johnson MP, Huang XM, Nichols DE.. (1992) Stereoselective LSD-like activity in d-lysergic acid amides of (R)- and (S)-2-aminobutane., 35 (2): [PMID:1732537] [10.1021/jm00080a001] |
| 10. Monte AP, Marona-Lewicka D, Lewis MM, Mailman RB, Wainscott DB, Nelson DL, Nichols DE.. (1998) Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity., 41 (12): [PMID:9622555] [10.1021/jm980076u] |
| 11. Glennon RA.. (2003) Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7)., 46 (14): [PMID:12825922] [10.1021/jm030030n] |
| 12. Monte AP, Marona-Lewicka D, Parker MA, Wainscott DB, Nelson DL, Nichols DE.. (1996) Dihydrobenzofuran analogues of hallucinogens. 3. Models of 4-substituted (2,5-dimethoxyphenyl)alkylamine derivatives with rigidified methoxy groups., 39 (15): [PMID:8709129] [10.1021/jm960199j] |
| 13. Chambers JJ, Parrish JC, Jensen NH, Kurrasch-Orbaugh DM, Marona-Lewicka D, Nichols DE.. (2003) Synthesis and pharmacological characterization of a series of geometrically constrained 5-HT(2A/2C) receptor ligands., 46 (16): [PMID:12877591] [10.1021/jm030064v] |
| 14. Oberlender R, Ramachandran PV, Johnson MP, Huang X, Nichols DE.. (1995) Effect of a chiral 4-alkyl substituent in hallucinogenic amphetamines., 38 (18): [PMID:7658446] [10.1021/jm00018a019] |
| 15. Gerasimov M, Marona-Lewicka D, Kurrasch-Orbaugh DM, Qandil AM, Nichols DE.. (1999) Further studies on oxygenated tryptamines with LSD-like activity incorporating a chiral pyrrolidine moiety into the side chain., 42 (20): [PMID:10514296] [10.1021/jm990325u] |
| 16. Nichols DE, Frescas S, Marona-Lewicka D, Kurrasch-Orbaugh DM.. (2002) Lysergamides of isomeric 2,4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N,N-diethyllysergamide (LSD)., 45 (19): [PMID:12213075] [10.1021/jm020153s] |
| 17. Blair JB, Kurrasch-Orbaugh D, Marona-Lewicka D, Cumbay MG, Watts VJ, Barker EL, Nichols DE.. (2000) Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines., 43 (24): [PMID:11101361] [10.1021/jm000339w] |
| 18. Arvidsson LE, Hacksell U, Johansson AM, Nilsson JL, Lindberg P, Sanchez D, Wikström H, Svensson K, Hjorth S, Carlsson A.. (1984) 8-Hydroxy-2-(alkylamino)tetralins and related compounds as central 5-hydroxytryptamine receptor agonists., 27 (1): [PMID:6418888] [10.1021/jm00367a009] |
| 19. Vázquez MJ, Roa AM, Reyes F, Vega A, Rivera-Sagredo A, Thomas DR, Díez E, Hueso-Rodríguez JA.. (2003) A novel ergot alkaloid as a 5-HT(1A) inhibitor produced by Dicyma sp., 46 (24): [PMID:14613313] [10.1021/jm0341204] |
| 20. Parker MA, Marona-Lewicka D, Lucaites VL, Nelson DL, Nichols DE.. (1998) A novel (benzodifuranyl)aminoalkane with extremely potent activity at the 5-HT2A receptor., 41 (26): [PMID:9857084] [10.1021/jm9803525] |
| 21. Vermeulen ES, Schmidt AW, Sprouse JS, Wikström HV, Grol CJ.. (2003) Characterization of the 5-HT(7) receptor. Determination of the pharmacophore for 5-HT(7) receptor agonism and CoMFA-based modeling of the agonist binding site., 46 (25): [PMID:14640545] [10.1021/jm030826m] |
| 22. Nichols DE, Brewster WK, Johnson MP, Oberlender R, Riggs RM.. (1990) Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amphetamine (MDA)., 33 (2): [PMID:1967651] [10.1021/jm00164a037] |
| 23. Glennon RA, Raghupathi R, Bartyzel P, Teitler M, Leonhardt S.. (1992) Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity., 35 (4): [PMID:1542100] [10.1021/jm00082a014] |
| 24. Oberlender RA, Kothari PJ, Nichols DE, Zabik JE.. (1984) Substituent branching in phenethylamine-type hallucinogens: a comparison of 1-[2,5-dimethoxy-4-(2-butyl)phenyl]-2-aminopropane and 1-[2,5-dimethoxy-4-(2-methylpropyl)phenyl]-2-aminopropane., 27 (6): [PMID:6737421] [10.1021/jm00372a015] |
| 25. Laban U, Kurrasch-Orbaugh D, Marona-Lewicka D, Nichols DE.. (2001) A novel fluorinated tryptamine with highly potent serotonin 5-HT1A receptor agonist properties., 11 (6): [PMID:11277522] [10.1016/s0960-894x(01)00062-2] |
| 26. Kothari PJ, Hathaway BA, Nichols DE, Yim GK.. (1981) Synthesis and serotonin-like activity of 2-amino-5,8-dimethoxy-6-methyl-1,2-dihydronaphthalene., 24 (7): [PMID:7277398] [10.1021/jm00139a022] |
| 27. Monte AP, Marona-Lewicka D, Kanthasamy A, Sanders-Bush E, Nichols DE.. (1995) Stereoselective LSD-like activity in a series of d-lysergic acid amides of (R)- and (S)-2-aminoalkanes., 38 (6): [PMID:7699712] [10.1021/jm00006a015] |
| 28. McLean TH, Chambers JJ, Parrish JC, Braden MR, Marona-Lewicka D, Kurrasch-Orbaugh D, Nichols DE.. (2006) C-(4,5,6-trimethoxyindan-1-yl)methanamine: a mescaline analogue designed using a homology model of the 5-HT2A receptor., 49 (14): [PMID:16821786] [10.1021/jm060272y] |
| 29. Sweetnam PM, Caldwell L, Lancaster J, Bauer C, McMillan B, Kinnier WJ, Price CH.. (1993) The role of receptor binding in drug discovery., 56 (4): [PMID:8496700] [10.1021/np50094a001] |
| 30. Nichols DE, Frescas SP, Chemel BR, Rehder KS, Zhong D, Lewin AH.. (2008) High specific activity tritium-labeled N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (INBMeO): a high-affinity 5-HT2A receptor-selective agonist radioligand., 16 (11): [PMID:18468904] [10.1016/j.bmc.2008.04.050] |
| 31. Thoma G, Baenteli R, Lewis I, Wagner T, Oberer L, Blum W, Glickman F, Streiff MB, Zerwes HG.. (2009) Special ergolines are highly selective, potent antagonists of the chemokine receptor CXCR3: discovery, characterization and preliminary SAR of a promising lead., 19 (21): [PMID:19783143] [10.1016/j.bmcl.2009.09.002] |
| 32. Lowe R, Glen RC, Mitchell JB.. (2010) Predicting phospholipidosis using machine learning., 7 (5): [PMID:20799726] [10.1021/mp100103e] |
| 33. Kruhlak NL, Choi SS, Contrera JF, Weaver JL, Willard JM, Hastings KL, Sancilio LF.. (2008) Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models., 18 (2): [PMID:20020916] [10.1080/15376510701857262] |
| 34. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, |
| 35. PubChem BioAssay data set, |
| 36. Noorizadeh H, Noorizadeh M, Farmany A. (2012) Advanced QSRR models of toxicological screening of basic drugs in whole blood by UPLC-TOFMS, 21 (12): [10.1007/s00044-012-9977-1] |
| 37. PubChem BioAssay data set, |
| 38. PubChem BioAssay data set, |
| 39. Jacob P, Anderson G, Meshul CK, Shulgin AT, Castagnoli N.. (1977) Monomethylthio analogues of 1-(2,4,5-trimethoxyphenyl)-2-aminopropane., 20 (10): [PMID:903913] [10.1021/jm00220a001] |
| 40. Unpublished dataset, |
| 41. Poulie CBM, Pottie E, Simon IA, Harpsøe K, D'Andrea L, Komarov IV, Gloriam DE, Jensen AA, Stove CP, Kristensen JL.. (2022) Discovery of β-Arrestin-Biased 25CN-NBOH-Derived 5-HT2A Receptor Agonists., 65 (18.0): [PMID:36099411] [10.1021/acs.jmedchem.2c00702] |
